PROMISE is laureate of 2017 Canceropole call
PROMISE was awarded for MADMAS project with HCL.
Close menu
Labelled alpha-synuclein
Alpha-synuclein aggregates to form insoluble fibrils in pathological conditions characterized by Lewy bodies, such as Parkinson's disease, dementia with Lewy bodies and multiple system atrophy. These disorders are known as synucleinopathies. Alpha-synuclein is the primary structural component of Lewy body fibrils.